NovaBay Non Current Liabilities Other from 2010 to 2024
| NBY Stock | USD 2.71 0.27 9.06% |
Non Current Liabilities Other | First Reported 2011-12-31 | Previous Quarter 342 K | Current Value 334 K | Quarterly Volatility 1.3 M |
Check NovaBay Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NovaBay Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 351 K, Interest Expense of 4.6 M or Other Operating Expenses of 16.9 M, as well as many indicators such as Price To Sales Ratio of 1.94, Dividend Yield of 0.0 or PTB Ratio of 8.63. NovaBay financial statements analysis is a perfect complement when working with NovaBay Pharmaceuticals Valuation or Volatility modules.
NovaBay | Non Current Liabilities Other |
Latest NovaBay Pharmaceuticals' Non Current Liabilities Other Growth Pattern
Below is the plot of the Non Current Liabilities Other of NovaBay Pharmaceuticals over the last few years. It is NovaBay Pharmaceuticals' Non Current Liabilities Other historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in NovaBay Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Non Current Liabilities Other | 10 Years Trend |
|
Non Current Liabilities Other |
| Timeline |
NovaBay Non Current Liabilities Other Regression Statistics
| Arithmetic Mean | 1,633,345 | |
| Geometric Mean | 978,309 | |
| Coefficient Of Variation | 88.48 | |
| Mean Deviation | 1,268,924 | |
| Median | 1,282,000 | |
| Standard Deviation | 1,445,187 | |
| Sample Variance | 2.1T | |
| Range | 4.4M | |
| R-Value | (0.58) | |
| Mean Square Error | 1.5T | |
| R-Squared | 0.34 | |
| Significance | 0.02 | |
| Slope | (187,344) | |
| Total Sum of Squares | 29.2T |
NovaBay Non Current Liabilities Other History
About NovaBay Pharmaceuticals Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include NovaBay Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. NovaBay Pharmaceuticals investors use historical funamental indicators, such as NovaBay Pharmaceuticals's Non Current Liabilities Other, to determine how well the company is positioned to perform in the future. Although NovaBay Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in NovaBay Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on NovaBay Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on NovaBay Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in NovaBay Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Non Current Liabilities Other | 300.6 K | 285.6 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for NovaBay Stock Analysis
When running NovaBay Pharmaceuticals' price analysis, check to measure NovaBay Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NovaBay Pharmaceuticals is operating at the current time. Most of NovaBay Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NovaBay Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NovaBay Pharmaceuticals' price. Additionally, you may evaluate how the addition of NovaBay Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.